Paul R Michl

Array ( [id] => 3688808 [patent_doc_number] => 05663298 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-02 [patent_title] => 'UCK14 compounds' [patent_app_type] => 1 [patent_app_number] => 8/730348 [patent_app_country] => US [patent_app_date] => 1996-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4135 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/663/05663298.pdf [firstpage_image] =>[orig_patent_app_number] => 730348 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3771806 [patent_doc_number] => 05734013 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-31 [patent_title] => 'Peptides having farnesyl transferase inhibiting properties and strain of genus streptomyces for producing same' [patent_app_type] => 1 [patent_app_number] => 8/716193 [patent_app_country] => US [patent_app_date] => 1996-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2826 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/734/05734013.pdf [firstpage_image] =>[orig_patent_app_number] => 716193 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3761100 [patent_doc_number] => 05741774 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-21 [patent_title] => 'Use of a cytokine regulatory agent to treat rheumatoid arthritis' [patent_app_type] => 1 [patent_app_number] => 8/722279 [patent_app_country] => US [patent_app_date] => 1996-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6372 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 223 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/741/05741774.pdf [firstpage_image] =>[orig_patent_app_number] => 722279 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3837837 [patent_doc_number] => 05846942 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-08 [patent_title] => 'Cholecystokinin antagonists, their preparation and therapeutic use' [patent_app_type] => 1 [patent_app_number] => 8/709316 [patent_app_country] => US [patent_app_date] => 1996-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 52860 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/846/05846942.pdf [firstpage_image] =>[orig_patent_app_number] => 709316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4274063 [patent_doc_number] => 06245900 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-12 [patent_title] => 'Platelet production promoting agent' [patent_app_type] => 1 [patent_app_number] => 8/696988 [patent_app_country] => US [patent_app_date] => 1996-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11902 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/245/06245900.pdf [firstpage_image] =>[orig_patent_app_number] => 696988 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3839700 [patent_doc_number] => 05744451 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-28 [patent_title] => 'N-substituted glutamic acid derivatives with interleukin-1 .beta. converting enzyme inhibitory activity' [patent_app_type] => 1 [patent_app_number] => 8/700716 [patent_app_country] => US [patent_app_date] => 1996-08-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5754 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 483 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/744/05744451.pdf [firstpage_image] =>[orig_patent_app_number] => 700716 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3792636 [patent_doc_number] => 05726154 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-10 [patent_title] => 'Stabilization and oral delivery of calcitonin' [patent_app_type] => 1 [patent_app_number] => 8/671870 [patent_app_country] => US [patent_app_date] => 1996-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 4727 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/726/05726154.pdf [firstpage_image] =>[orig_patent_app_number] => 671870 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3771146 [patent_doc_number] => 05756461 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-26 [patent_title] => 'Methods for treating diabetes' [patent_app_type] => 1 [patent_app_number] => 8/678369 [patent_app_country] => US [patent_app_date] => 1996-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10899 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/756/05756461.pdf [firstpage_image] =>[orig_patent_app_number] => 678369 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3805684 [patent_doc_number] => 05830868 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-03 [patent_title] => 'Substituted DI- and tripeptide inhibitors of protein: farnesyl transferase' [patent_app_type] => 1 [patent_app_number] => 8/671460 [patent_app_country] => US [patent_app_date] => 1996-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14956 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 43 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/830/05830868.pdf [firstpage_image] =>[orig_patent_app_number] => 671460 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4034016 [patent_doc_number] => 05942488 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-08-24 [patent_title] => 'Haemoglobin' [patent_app_type] => 1 [patent_app_number] => 8/619708 [patent_app_country] => US [patent_app_date] => 1996-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 6 [patent_no_of_words] => 5483 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/942/05942488.pdf [firstpage_image] =>[orig_patent_app_number] => 619708 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4110951 [patent_doc_number] => 06057423 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-02 [patent_title] => 'Integrin alpha subunit' [patent_app_type] => 1 [patent_app_number] => 8/663731 [patent_app_country] => US [patent_app_date] => 1996-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 9 [patent_no_of_words] => 21198 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/057/06057423.pdf [firstpage_image] =>[orig_patent_app_number] => 663731 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3787247 [patent_doc_number] => 05840697 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Peptide inhibitors of calmodulin' [patent_app_type] => 1 [patent_app_number] => 8/660747 [patent_app_country] => US [patent_app_date] => 1996-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 16621 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840697.pdf [firstpage_image] =>[orig_patent_app_number] => 660747 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3687691 [patent_doc_number] => 05696082 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-09 [patent_title] => 'Hydroxamic acid derivatives' [patent_app_type] => 1 [patent_app_number] => 8/530374 [patent_app_country] => US [patent_app_date] => 1996-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 13585 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/696/05696082.pdf [firstpage_image] =>[orig_patent_app_number] => 530374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4006599 [patent_doc_number] => 06005078 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-21 [patent_title] => 'Canine-derived hemoglobin blood substitute, the process for preparing same and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/645744 [patent_app_country] => US [patent_app_date] => 1996-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 8831 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 209 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/005/06005078.pdf [firstpage_image] =>[orig_patent_app_number] => 645744 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3761184 [patent_doc_number] => 05741779 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-21 [patent_title] => 'Antithrombotic materials and methods' [patent_app_type] => 1 [patent_app_number] => 8/644290 [patent_app_country] => US [patent_app_date] => 1996-05-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15632 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/741/05741779.pdf [firstpage_image] =>[orig_patent_app_number] => 644290 [rel_patent_id] =>[rel_patent_doc_number] =>)